Literature DB >> 3219195

Determination of parameters for enzyme therapy using L-asparaginase entrapped in canine erythrocytes.

A Naqi1, J R DeLoach, K Andrews, W Satterfield, M Keeling.   

Abstract

The antitumor agent L-asparaginase was entrapped in canine erythrocytes by a single dialysis encapsulation (efficiency mean = 30%). Concentration of asparaginase in carrier cells was about 240 IU/ml, with an average of 62% cell recovery. Use of a double dialysis procedure increased the L-asparaginase concentration within carrier cells to 530 IU/ml, with an overall cell recovery of 53.9%. In vitro efflux experiments showed L-asparaginase-loaded canine carriers were stable at both 4 and 37 degrees C for an 18-h period. In vivo cell survival studies showed that carrier cells did circulate and that L-asparaginase had a half-life of 6.5 days. No evidence suggesting that the enzyme left the cell was found. Carrier cells prepared with [3H]inulin and [14C]sucrose were stored at 4 degrees C for 2 weeks and began to show signs of deterioration after 2 days.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219195

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  2 in total

1.  Modulated red blood cell survival by membrane protein clustering.

Authors:  L Chiarantini; L Rossi; A Fraternale; M Magnani
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

2.  In vivo half life of nanoencapsulated L-asparaginase.

Authors:  E T Baran; N Ozer; V Hasirci
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.